Tech Company Financing Transactions

Labrys Biologics Funding Round

Canaan Partners, InterWest Partners and Sofinnova Ventures joined a $31 million Series A capital raise for Labrys Biologics. The funding round was announced on 1/4/2013.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

Canaan Partners (Wende Hutton)

InterWest Partners (Nina Kjellson)

Sofinnova Ventures (Michael Powell)

venBio (Corey Goodman)

Proceeds Purpose
Under the terms of the agreement with Pfizer, Labrys acquired worldwide rights to RN-307.

Company Information

Company Status
Acquired or Merged
Mailing Address
1700 Owens Street 595
San Francisco, CA 94158
Email Address
Not Recorded
Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine. Labrys' lead candidate, RN-307, is an anti-CGRP monoclonal antibody for the treatment of chronic migraine slated to enter Phase 2 clinical trials in 2013.
Labrys Biologics LinkedIn Company Profile
Social Media
Labrys Biologics Company Twitter Account
Company News
Labrys Biologics News
Labrys Biologics on Facebook
Labrys Biologics on YouTube

Management Team

Email & Social
Chief Executive Officer
Steven James
  Steven James LinkedIn Profile  Steven James Twitter Account  Steven James News  Steven James on Facebook
Chief Medical Officer
Marcelo Bigal
  Marcelo Bigal LinkedIn Profile  Marcelo Bigal Twitter Account  Marcelo Bigal News  Marcelo Bigal on Facebook
VP - Product Management
Michael Chang
  Michael Chang LinkedIn Profile  Michael Chang Twitter Account  Michael Chang News  Michael Chang on Facebook
VP - Regulatory Affairs
Michele Bronson
  Michele Bronson LinkedIn Profile  Michele Bronson Twitter Account  Michele Bronson News  Michele Bronson on Facebook



Browse more venture capital transactions:

Prev: 1/4/2013: Webvanta venture capital transaction
Next: 1/4/2013: Xtera Communications venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary